CorMedix (CRMD) Times Interest Earned (2012 - 2025)
CorMedix (CRMD) reported Times Interest Earned of $23.01 for Q4 2025, up 120.81% on a YoY basis from $10.42 in Q4 2024, and up 12449.41% sequentially from $0.18 in Q3 2025.
CorMedix (CRMD) Times Interest Earned (2012 - 2025) Analysis & Trends
CorMedix (CRMD) has 14 years of Times Interest Earned data on file, last reported at $23.01 in Q4 2025.
- For the quarter ending Q4 2025, Times Interest Earned rose 120.81% year-over-year to $23.01; the trailing twelve-month figure through Dec 2025 stood at $59.82 (down 97.48% YoY), and the FY2025 full-year result was $1.32, up 239.66% from the prior year.
- Times Interest Earned advanced to $23.01 in Q4 2025, from $0.18 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of $37.97 in Q1 2025 to a low of -$2390.0 in Q4 2023.
- A 5-year average of -$364.97 and a median of -$77.5 in 2024 frame the typical range for Times Interest Earned.
- Across the five-year window, Times Interest Earned slumped 111912.64% in 2022 and jumped 138.42% in 2025, its largest moves.
- Tracing CRMD's Times Interest Earned over 5 years: stood at -$1446.6 in 2021, then soared by 96.8% to -$46.28 in 2022, then slumped by 5063.87% to -$2390.0 in 2023, then soared by 95.37% to -$110.58 in 2024, then surged by 120.81% to $23.01 in 2025.
- Business Quant data shows CRMD's Times Interest Earned at $23.01 in Q4 2025, $0.18 in Q3 2025, and $8.19 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | CorMedix | 546.82 Mn | 391.62 Mn | 107.31 Mn | 23.01 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 23.01 |
| Sep 30, 2025 | 0.18 |
| Jun 30, 2025 | 8.19 |
| Mar 31, 2025 | 37.97 |
| Dec 31, 2024 | -110.58 |
| Sep 30, 2024 | -64.46 |
| Jun 30, 2024 | -90.54 |
| Mar 31, 2024 | -98.84 |
| Dec 31, 2023 | -2,389.99 |
| Sep 30, 2023 | -209.35 |
| Jun 30, 2023 | -236.09 |
| Mar 31, 2023 | -220.34 |
| Dec 31, 2022 | -46.28 |
| Sep 30, 2022 | -139.24 |
| Jun 30, 2022 | -2,298.59 |
| Mar 31, 2022 | -6.15 |
| Dec 31, 2021 | -1,446.62 |
| Sep 30, 2021 | -9.00 |
| Jun 30, 2021 | -2.05 |
| Mar 31, 2021 | -0.72 |